ID: ALA2314271

Max Phase: Preclinical

Molecular Formula: C25H22N2O3

Molecular Weight: 398.46

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(O)Cc1c[nH]c2ccc(OCCCn3c4ccccc4c4ccccc43)cc12

Standard InChI:  InChI=1S/C25H22N2O3/c28-25(29)14-17-16-26-22-11-10-18(15-21(17)22)30-13-5-12-27-23-8-3-1-6-19(23)20-7-2-4-9-24(20)27/h1-4,6-11,15-16,26H,5,12-14H2,(H,28,29)

Standard InChI Key:  SUMUJPPQCGLXEB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 398.46

Molecular Weight (Monoisotopic): 398.1630

AlogP: 5.37

#Rotatable Bonds: 7

Polar Surface Area: 67.25

Molecular Species: ACID

HBA: 3

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 4.23

CX Basic pKa:

CX LogP: 4.76

CX LogD: 1.74

Aromatic Rings: 5

Heavy Atoms: 30

QED Weighted: 0.36

Np Likeness Score: -0.53

References

1. Gim HJ, Li H, Lee E, Ryu JH, Jeon R..  (2013)  Design and synthesis of alkoxyindolyl-3-acetic acid analogs as peroxisome proliferator-activated receptor-γ/δ agonists.,  23  (2): [PMID:23265886] [10.1016/j.bmcl.2012.11.033]

Source

Source(1):

• Scientific Literature